Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 5/20 | 0.55 |
| ▸ | ITGAV | P06756 | 5/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 2/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | PIM1 | P11309 | 1/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.45 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.45 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.45 |
| ▸ | FLT3 | P36888 | 1/20 | 0.45 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.45 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.45 |
| ▸ | FABP1 | P07148 | 1/20 | 0.45 |
| ▸ | FABP6 | P51161 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5846445 | 0.92 | ITGB3 (0.62) | ITGB3ITGAVSMN1; SMN2HTTITGB5 | |
| SCHEMBL5845065 | 0.92 | ITGB3 (0.59) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 | |
| SCHEMBL10401970 | 0.83 | CYP1A2 (0.53) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 | |
| SCHEMBL534155 | 0.81 | GAA (0.56) | ITGB3ITGAVSMN1; SMN2CYP1A2RAB9A | |
| Hydrochloric Acid SCHEMBL360682 | 0.81 | GAA (0.56) | ITGB3ITGAVSMN1; SMN2CYP1A2RAB9A | |
| SCHEMBL7168552 | 0.80 | ITGB3 (0.62) | ITGB3ITGAVSMN1; SMN2GAAITGB5 | |
| SCHEMBL10401969 | 0.80 | CYP2C19 (0.56) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 | |
| SCHEMBL5843886 | 0.79 | ITGB3 (0.46) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 | |
| SCHEMBL31483042 | 0.78 | CYP1A2 (0.51) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 | |
| SCHEMBL8145501 | 0.78 | CYP1A2 (0.56) | ITGB3ITGAVSMN1; SMN2HTTCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7135587-B2 | Urea and urethane derivatives as integrin inhibitors | MERCK PATENT GMBH (DE) | 2006-11-14 | — | — | US | disclosed |
| EP-1343764-B1 | UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GMBH (DE) | 2004-08-25 | — | — | EP | disclosed |
| US-20040063644-A1 | Urea and urethane derivatives as integrin inhibitors | MERCK PATENT GMBH (DE) | 2004-04-01 | — | — | US | disclosed |
| EP-1343764-A1 | UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GmbH (DE) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002050039-A1 | UREA AND URETHANE DERIVATIVES AS INTEGRIN INHIBITORS | MERCK PATENT GMBH (DE) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063644-A1 | Urea and urethane derivatives as integrin inhibitors | ITGB1, ITGB2, ITGA1 | ITGB3 7/4885ITGAV 16/4885SMN1; SMN2 3335/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.